Breaking News Instant updates and real-time market news.

CB

Chubb

$190.29 /

+3.315 (+1.77%)

06:48
10/28/21
10/28
06:48
10/28/21
06:48

Chubb price target raised to $225 from $195 at RBC Capital

RBC Capital analyst Mark Dwelle raised the firm's price target on Chubb to $225 from $195 and keeps an Outperform rating on the shares. The company's Q3 results were "noticeably strong" with pricing increases and margin improvement, even though catastrophe losses were "elevated", the analyst tells investors in a research note.

CB Chubb
$190.29 /

+3.315 (+1.77%)

10/28/21 Barclays
Chubb price target raised to $227 from $192 at Barclays
10/27/21 JMP Securities
Chubb price target raised to $210 from $200 at JMP Securities
10/15/21 Morgan Stanley
Chubb resumed with an Equal Weight at Morgan Stanley
08/16/21 Wolfe Research
Chubb initiated with an Outperform at Wolfe Research

TODAY'S FREE FLY STORIES

Hot Stocks
Immunome submits IND to FDA for IMM-BCP-01 to treat SARS-CoV-2 » 07:07
11/29/21
11/29
07:07
11/29/21
07:07
IMNM

Immunome

$16.74 /

+1.42 (+9.27%)

Immunome announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IMNM Immunome
$16.74 /

+1.42 (+9.27%)

IMNM Immunome
$16.74 /

+1.42 (+9.27%)

10/29/21 Cantor Fitzgerald
Immunome initiated with an Overweight at Cantor Fitzgerald
08/20/21 Chardan
Immunome price target raised to $21 from $18 at Chardan
Hot Stocks
G1 Therapeutics initiates Phase 2 trial of trilaciclib with Trodelvy » 07:06
11/29/21
11/29
07:06
11/29/21
07:06
GTHX

G1 Therapeutics

$13.04 /

-0.59 (-4.33%)

G1 Therapeutics announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GTHX G1 Therapeutics
$13.04 /

-0.59 (-4.33%)

GTHX G1 Therapeutics
$13.04 /

-0.59 (-4.33%)

11/04/21 JPMorgan
G1 Therapeutics downgraded to Underweight from Neutral at JPMorgan
11/04/21 H.C. Wainwright
G1 Therapeutics price target lowered to $71 from $78 at H.C. Wainwright
11/03/21 Roth Capital
G1 Therapeutics price target lowered to $54 from $56 at Roth Capital
10/14/21 BTIG
G1 Therapeutics assumed with a Buy at BTIG
GTHX G1 Therapeutics
$13.04 /

-0.59 (-4.33%)

GTHX G1 Therapeutics
$13.04 /

-0.59 (-4.33%)

Recommendations
Wintrust Financial price target raised to $112 from $108 at Raymond James » 07:05
11/29/21
11/29
07:05
11/29/21
07:05
WTFC

Wintrust Financial

$91.11 /

-5.36 (-5.56%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WTFC Wintrust Financial
$91.11 /

-5.36 (-5.56%)

WTFC Wintrust Financial
$91.11 /

-5.36 (-5.56%)

10/21/21 Truist
Wintrust Financial price target raised to $105 from $88 at Truist
10/21/21 RBC Capital
Wintrust Financial price target raised to $100 from $92 at RBC Capital
10/21/21 Raymond James
Wintrust Financial price target raised to $108 from $91 at Raymond James
10/21/21 Janney Montgomery Scott
Wintrust Financial downgraded to Neutral from Buy at Janney Montgomery Scott
WTFC Wintrust Financial
$91.11 /

-5.36 (-5.56%)

Hot Stocks
Dana TM4 to establish new electrodynamics facility in Sweden » 07:05
11/29/21
11/29
07:05
11/29/21
07:05
DAN

Dana

$22.73 /

-1.275 (-5.31%)

Dana Incorporated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DAN Dana
$22.73 /

-1.275 (-5.31%)

DAN Dana
$22.73 /

-1.275 (-5.31%)

10/27/21 RBC Capital
Dana price target lowered to $25 from $28 at RBC Capital
10/27/21 Deutsche Bank
Dana price target lowered to $31 from $35 at Deutsche Bank
09/16/21 BofA
BofA upgrades Dana to Buy on diversification, electrification
09/16/21 BofA
Dana upgraded to Buy from Neutral at BofA
DAN Dana
$22.73 /

-1.275 (-5.31%)

Recommendations
Rezolute price target lowered to $17 from $30 at Canaccord » 07:05
11/29/21
11/29
07:05
11/29/21
07:05
RZLT

Rezolute

$5.28 /

-0.11 (-2.04%)

Canaccord analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RZLT Rezolute
$5.28 /

-0.11 (-2.04%)

RZLT Rezolute
$5.28 /

-0.11 (-2.04%)

11/15/21 JMP Securities
Rezolute price target lowered to $18 from $30 at JMP Securities
09/16/21 Roth Capital
2022 will be 'value-inflection point' for Rezolute , says Roth Capital
09/08/21 Roth Capital
Rezolute initiated with a Buy at Roth Capital
05/26/21 Oppenheimer
Oppenheimer starts Rezolute with an Outperform on upcoming Phase IIb RZ358 data
RZLT Rezolute
$5.28 /

-0.11 (-2.04%)

  • 13
    Oct
RZLT Rezolute
$5.28 /

-0.11 (-2.04%)

Hot Stocks
Lee Enterprises comments on purported director nominations from Alden » 07:05
11/29/21
11/29
07:05
11/29/21
07:05
LEE

Lee Enterprises

$24.25 /

-0.25 (-1.02%)

Lee Enterprises commented…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LEE Lee Enterprises
$24.25 /

-0.25 (-1.02%)

LEE Lee Enterprises
$24.25 /

-0.25 (-1.02%)

LEE Lee Enterprises
$24.25 /

-0.25 (-1.02%)

LEE Lee Enterprises
$24.25 /

-0.25 (-1.02%)

Hot Stocks
European Wax Center appoints Nital Scott to board of directors » 07:05
11/29/21
11/29
07:05
11/29/21
07:05
EWCZ

European Wax Center

$26.68 /

-0.85 (-3.09%)

European Wax Center…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EWCZ European Wax Center
$26.68 /

-0.85 (-3.09%)

EWCZ European Wax Center
$26.68 /

-0.85 (-3.09%)

08/30/21 BofA
BofA starts 'market share gainer' European Wax Center at Buy
08/30/21 Truist
Truist starts European Wax Center at Buy, sees market share gains
08/30/21 Jefferies
European Wax Center initiated with a Buy at Jefferies
08/30/21 Morgan Stanley
Morgan Stanley starts European Wax Center at Equal Weight with $25 price target
EWCZ European Wax Center
$26.68 /

-0.85 (-3.09%)

  • 11
    Nov
  • 05
    Aug
EWCZ European Wax Center
$26.68 /

-0.85 (-3.09%)

Hot Stocks
Olaplex Holdings, Ulta Beauty announces expansion of distribution partnership » 07:04
11/29/21
11/29
07:04
11/29/21
07:04
OLPX

Olaplex Holdings

$26.34 /

-0.61 (-2.26%)

, ULTA

Ulta Beauty

$399.50 /

-9.93 (-2.43%)

Olaplex Holdings…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OLPX Olaplex Holdings
$26.34 /

-0.61 (-2.26%)

ULTA Ulta Beauty
$399.50 /

-9.93 (-2.43%)

OLPX Olaplex Holdings
$26.34 /

-0.61 (-2.26%)

11/08/21 Morgan Stanley
Olaplex Holdings upgraded to Overweight after pullback at Morgan Stanley
11/08/21 Morgan Stanley
Olaplex Holdings upgraded to Overweight from Equal Weight at Morgan Stanley
10/25/21 Raymond James
Olaplex Holdings initiated with a Strong Buy at Raymond James
10/25/21 Cowen
Cowen starts Olaplex at Outperform with $33 price target
ULTA Ulta Beauty
$399.50 /

-9.93 (-2.43%)

10/20/21 Cowen
Ulta Beauty price target lowered to $440 from $490 at Cowen
10/20/21 BofA
Ulta Beauty price target lowered to $400 from $430 at BofA
10/20/21 William Blair
Ulta Beauty should be bought on yesterday's selloff, says William Blair
10/20/21 Baird
Ulta Beauty risk/reward attractive at current levels, says Baird
OLPX Olaplex Holdings
$26.34 /

-0.61 (-2.26%)

ULTA Ulta Beauty
$399.50 /

-9.93 (-2.43%)

  • 30
    Sep
ULTA Ulta Beauty
$399.50 /

-9.93 (-2.43%)

OLPX Olaplex Holdings
$26.34 /

-0.61 (-2.26%)

ULTA Ulta Beauty
$399.50 /

-9.93 (-2.43%)

OLPX Olaplex Holdings
$26.34 /

-0.61 (-2.26%)

ULTA Ulta Beauty
$399.50 /

-9.93 (-2.43%)

Upgrade
Raymond James upgrades Copa to Strong Buy on 'compelling opportunity' » 07:04
11/29/21
11/29
07:04
11/29/21
07:04
CPA

Copa Holdings

$71.67 /

-5.7 (-7.37%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CPA Copa Holdings
$71.67 /

-5.7 (-7.37%)

CPA Copa Holdings
$71.67 /

-5.7 (-7.37%)

06:20 Today Raymond James
Copa Holdings upgraded to Strong Buy from Outperform at Raymond James
11/23/21 JPMorgan
Copa Holdings upgraded to Neutral from Underweight at JPMorgan
11/19/21 Citi
Citi ups Copa target to $130, opens 'positive catalyst watch'
08/31/21 Credit Suisse
Copa Holdings price target raised to $100 from $90 at Credit Suisse
CPA Copa Holdings
$71.67 /

-5.7 (-7.37%)

Hot Stocks
Adagio Therapeutics prvides information of ADG20 to address Omicron variant » 07:03
11/29/21
11/29
07:03
11/29/21
07:03
ADGI

Adagio Therapeutics

$25.06 /

+6.33 (+33.80%)

Adagio Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ADGI Adagio Therapeutics
$25.06 /

+6.33 (+33.80%)

ADGI Adagio Therapeutics
$25.06 /

+6.33 (+33.80%)

06:48 Today Morgan Stanley
Morgan Stanley, assuming Omicron becomes dominant, ups Adagio to Overweight
06:18 Today Morgan Stanley
Adagio Therapeutics upgraded to Overweight from Equal Weight at Morgan Stanley
11/05/21 Stifel
Stifel sees 'zero change' to Adagio, AbCellera theses due to Pfizer data
10/01/21 Stifel
AbCellera, Adagio reactions to Merck data look 'overdone,' says Stifel
ADGI Adagio Therapeutics
$25.06 /

+6.33 (+33.80%)

  • 06
    Aug
ADGI Adagio Therapeutics
$25.06 /

+6.33 (+33.80%)

Hot Stocks
Shawcor receives LOI from third party to purchase Rexdale property » 07:02
11/29/21
11/29
07:02
11/29/21
07:02
SAWLF

Shawcor

$3.55 /

-0.22 (-5.84%)

Shawcor announced its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SAWLF Shawcor
$3.55 /

-0.22 (-5.84%)

SAWLF Shawcor
$3.55 /

-0.22 (-5.84%)

11/11/21 National Bank
Shawcor price target lowered to C$8.50 from C$8.75 at National Bank
11/11/21 BMO Capital
Shawcor price target lowered to C$6.50 from C$7 at BMO Capital
08/11/21 TD Securities
Shawcor price target raised to C$9.50 from C$9 at TD Securities
05/26/21 TD Securities
Shawcor upgraded to Buy from Hold at TD Securities
Upgrade
Stephens upgrades Truist to Overweight on upcoming peer leading profitability » 07:01
11/29/21
11/29
07:01
11/29/21
07:01
TFC

Truist Financial

$59.58 /

-3.32 (-5.28%)

Stephens analyst Terry…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TFC Truist Financial
$59.58 /

-3.32 (-5.28%)

TFC Truist Financial
$59.58 /

-3.32 (-5.28%)

06:18 Today Stephens
Truist Financial upgraded to Overweight from Equal Weight at Stephens
10/22/21 Raymond James
Marsh McLennan upgraded to Outperform from Underperform at Raymond James
10/11/21 Jefferies
Truist Financial price target raised to $66 from $61 at Jefferies
10/05/21 Wolfe Research
Truist downgraded to Underperform from Outperform at Wolfe Research
TFC Truist Financial
$59.58 /

-3.32 (-5.28%)

TFC Truist Financial
$59.58 /

-3.32 (-5.28%)

Hot Stocks
FDA accepts Bristol-Myers' NDA for deucravacitinib in severe plaque psoriasis » 07:01
11/29/21
11/29
07:01
11/29/21
07:01
BMY

Bristol-Myers

$56.30 /

-0.51 (-0.90%)

The company states:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BMY Bristol-Myers
$56.30 /

-0.51 (-0.90%)

BMY Bristol-Myers
$56.30 /

-0.51 (-0.90%)

11/23/21 Societe Generale
Societe Generale upgrades AbbVie to Buy on better than anticipated execution
11/18/21 BMO Capital
Bristol-Myers initiated with an Outperform at BMO Capital
11/15/21 Evercore ISI
Ventyx Biosciences initiated with an Outperform at Evercore ISI
11/15/21 Jefferies
Jefferies starts Ventyx at Buy based on blockbuster potential
BMY Bristol-Myers
$56.30 /

-0.51 (-0.90%)

BMY Bristol-Myers
$56.30 /

-0.51 (-0.90%)

BMY Bristol-Myers
$56.30 /

-0.51 (-0.90%)

BMY Bristol-Myers
$56.30 /

-0.51 (-0.90%)

Hot Stocks
NRx Pharmaceuticals completes analysis of ZYESAMI treatment in COVID-19 » 07:00
11/29/21
11/29
07:00
11/29/21
07:00
NRXP

NRx Pharmaceuticals

$7.11 /

+2.61 (+58.00%)

NRx Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NRXP NRx Pharmaceuticals
$7.11 /

+2.61 (+58.00%)

NRXP NRx Pharmaceuticals
$7.11 /

+2.61 (+58.00%)

NRXP NRx Pharmaceuticals
$7.11 /

+2.61 (+58.00%)

Hot Stocks
TransUnion pledges to reach net-zero scope 1, 2 greenhouse gas emissions by 2025 » 06:58
11/29/21
11/29
06:58
11/29/21
06:58
TRU

TransUnion

$111.34 /

-2.87 (-2.51%)

TransUnion announced its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TRU TransUnion
$111.34 /

-2.87 (-2.51%)

TRU TransUnion
$111.34 /

-2.87 (-2.51%)

11/23/21 Atlantic Equities
Atlantic Equities upgrades TransUnion on 'lower than feared' dilution
11/23/21 Atlantic Equities
TransUnion upgraded to Overweight from Neutral at Atlantic Equities
09/14/21 Baird
TransUnion acquisition a good strategic fit, says Baird
08/17/21 Barclays
TransUnion price target raised to $140 from $130 at Barclays
TRU TransUnion
$111.34 /

-2.87 (-2.51%)

TRU TransUnion
$111.34 /

-2.87 (-2.51%)

Hot Stocks
SpringsWorks Therapeutics announces full enrollment of Phase 2b ReNeu trial » 06:57
11/29/21
11/29
06:57
11/29/21
06:57
SWTX

SpringsWorks Therapeutics

$68.47 /

-1.68 (-2.39%)

SpringWorks Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SWTX SpringsWorks Therapeutics
$68.47 /

-1.68 (-2.39%)

SWTX SpringsWorks Therapeutics
$68.47 /

-1.68 (-2.39%)

10/27/21 Wedbush
Wedbush recommends buying SpringsWorks shares ahead of BLENREP combo data
09/08/21 JPMorgan
SpringsWorks price target raised to $105 from $97 at JPMorgan
07/21/21 H.C. Wainwright
SpringsWorks price target raised to $136 from $124 at H.C. Wainwright
07/20/21 Goldman Sachs
SpringsWorks Therapeutics price target raised to $123 from $107 at Goldman Sachs
SWTX SpringsWorks Therapeutics
$68.47 /

-1.68 (-2.39%)

  • 02
    Mar
Initiation
Raymond James starts 'undisputed market leader' Cadre at Outperform » 06:56
11/29/21
11/29
06:56
11/29/21
06:56
CDRE

Cadre

$19.40 /

-0.1 (-0.51%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CDRE Cadre
$19.40 /

-0.1 (-0.51%)

CDRE Cadre
$19.40 /

-0.1 (-0.51%)

06:30 Today Raymond James
Cadre initiated with an Outperform at Raymond James
05:31 Today B. Riley
Cadre initiated with a Buy at B. Riley
  • 04
    Nov
CDRE Cadre
$19.40 /

-0.1 (-0.51%)

Hot Stocks
Asensus Surgical announces Senhance Robotic System order from RZD » 06:56
11/29/21
11/29
06:56
11/29/21
06:56
ASXC

Asensus Surgical

$1.43 /

-0.04 (-2.72%)

Asensus Surgical…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ASXC Asensus Surgical
$1.43 /

-0.04 (-2.72%)

ASXC Asensus Surgical
$1.43 /

-0.04 (-2.72%)

09/29/21 H.C. Wainwright
H.C. Wainwright sees 'positive signals' for Asensus after Japan pact
05/26/21 H.C. Wainwright
Asensus Surgical initiated with a Buy at H.C. Wainwright
ASXC Asensus Surgical
$1.43 /

-0.04 (-2.72%)

ASXC Asensus Surgical
$1.43 /

-0.04 (-2.72%)

Hot Stocks
Drive Shack to bring Puttery to Philadelphia's Fishtown neighborhood » 06:55
11/29/21
11/29
06:55
11/29/21
06:55
DS

Drive Shack

$2.02 /

-0.045 (-2.18%)

Drive Shack announced it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DS Drive Shack
$2.02 /

-0.045 (-2.18%)

DS Drive Shack
$2.02 /

-0.045 (-2.18%)

08/09/21 Craig-Hallum
Craig-Hallum bullish on Drive Shack after 'significant' Q2 beat
03/26/21 Craig-Hallum
Drive Shack initiated with a Buy at Craig-Hallum
03/12/21 BTIG
Drive Shack cost cuts should be 'largely permanent,' says BTIG
12/17/20 B. Riley Securities
Drive Shack price target raised to $5.50 from $4 at B. Riley Securities
DS Drive Shack
$2.02 /

-0.045 (-2.18%)

  • 29
    Jan
Hot Stocks
Becton Dickinson appoints Joseph Smith as chief scientific officer » 06:54
11/29/21
11/29
06:54
11/29/21
06:54
BDX

Becton Dickinson

$238.46 /

-6.01 (-2.46%)

Becton Dickinson…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BDX Becton Dickinson
$238.46 /

-6.01 (-2.46%)

BDX Becton Dickinson
$238.46 /

-6.01 (-2.46%)

11/12/21 Piper Sandler
Becton Dickinson shares can move higher after investor day, says Piper Sandler
08/26/21 Piper Sandler
Becton Dickinson Covid test approval 'nice positive,' says Piper Sandler
08/06/21 JPMorgan
Becton Dickinson downgraded to Neutral at JPMorgan on 'muted' FY22 outlook
08/06/21 JPMorgan
Becton Dickinson downgraded to Neutral from Overweight at JPMorgan
BDX Becton Dickinson
$238.46 /

-6.01 (-2.46%)

BDX Becton Dickinson
$238.46 /

-6.01 (-2.46%)

Hot Stocks
Karuna Therapeutics appoints Charmaine Lykins as CCO » 06:54
11/29/21
11/29
06:54
11/29/21
06:54
KRTX

Karuna Therapeutics

$129.78 /

-4.7 (-3.49%)

Karuna Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KRTX Karuna Therapeutics
$129.78 /

-4.7 (-3.49%)

KRTX Karuna Therapeutics
$129.78 /

-4.7 (-3.49%)

11/08/21 Oppenheimer
Karuna Therapeutics price target raised to $175 from $148 at Oppenheimer
11/05/21 Mizuho
Karuna Therapeutics price target raised to $182 from $150 at Mizuho
11/04/21 Stifel
Karuna Therapeutics price target raised to $185 from $154 at Stifel
09/30/21 JPMorgan
Karuna Therapeutics initiated with an Overweight at JPMorgan
KRTX Karuna Therapeutics
$129.78 /

-4.7 (-3.49%)

  • 10
    Nov
  • 02
    Mar
Hot Stocks
European Commission approves KEYTRUDA plus LENVIMA for endometrial carcinoma » 06:53
11/29/21
11/29
06:53
11/29/21
06:53
MRK

Merck

$78.65 /

-3.65 (-4.43%)

, ESALY

Eisai

$62.28 /

+0.14 (+0.23%)

Merck and Eisai announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRK Merck
$78.65 /

-3.65 (-4.43%)

ESALY Eisai
$62.28 /

+0.14 (+0.23%)

MRK Merck
$78.65 /

-3.65 (-4.43%)

05:29 Today Citi
Merck downgraded to Neutral from Buy at Citi
11/24/21 Truist
Merck price target raised to $95 from $92 at Truist
11/18/21 BMO Capital
Merck initiated with a Market Perform at BMO Capital
11/18/21 Stifel
Insmed fits similar 'profile' to Dicerna in terms of value, says Stifel
ESALY Eisai
$62.28 /

+0.14 (+0.23%)

10/08/21 Jefferies
Biogen price target lowered to $400 from $500 at Jefferies
09/30/21 RBC Capital
Prothena price target raised to $82 from $59 at RBC Capital
06/25/21 Morgan Stanley
Eisai downgraded to Equal Weight from Overweight at Morgan Stanley
06/17/21 JPMorgan
Eisai upgraded to Overweight from Neutral at JPMorgan
MRK Merck
$78.65 /

-3.65 (-4.43%)

MRK Merck
$78.65 /

-3.65 (-4.43%)

ESALY Eisai
$62.28 /

+0.14 (+0.23%)

MRK Merck
$78.65 /

-3.65 (-4.43%)

ESALY Eisai
$62.28 /

+0.14 (+0.23%)

MRK Merck
$78.65 /

-3.65 (-4.43%)

Downgrade
Amundi downgraded to Equal Weight from Overweight at Morgan Stanley » 06:53
11/29/21
11/29
06:53
11/29/21
06:53
AMDUF

Amundi

$90.53 /

+ (+0.00%)

, MNGPF

Man Group

$3.02 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMDUF Amundi
$90.53 /

+ (+0.00%)

07/12/21 Morgan Stanley
Amundi price target raised to EUR 89.60 from EUR 88.40 at Morgan Stanley
07/12/21 Berenberg
Amundi price target raised to EUR 88 from EUR 85 at Berenberg
07/01/21 Deutsche Bank
Amundi price target lowered to EUR 77 from EUR 79 at Deutsche Bank
02/17/21 RBC Capital
Amundi price target raised to EUR 77 from EUR 75 at RBC Capital
MNGPF Man Group
$3.02 /

+ (+0.00%)

10/21/21 UBS
Man Group price target raised to 260 GBp from 245 GBp at UBS
10/18/21 Morgan Stanley
Man Group price target raised to 275 GBp from 253 GBp at Morgan Stanley
10/14/21 JPMorgan
Man Group price target raised to 280 GBp from 270 GBp at JPMorgan
10/14/21 Barclays
Man Group price target raised to 235 GBp from 210 GBp at Barclays
Initiation
Claros Mortgage initiated with a Market Perform at Keefe Bruyette » 06:52
11/29/21
11/29
06:52
11/29/21
06:52
CMTG

Claros Mortgage

$16.97 /

-0.06 (-0.35%)

Keefe Bruyette analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CMTG Claros Mortgage
$16.97 /

-0.06 (-0.35%)

06:35 Today UBS
Claros Mortgage initiated with a Neutral at UBS
06:35 Today JPMorgan
Claros Mortgage initiated with an Overweight at JPMorgan
06:34 Today JMP Securities
Claros Mortgage initiated with an Outperform at JMP Securities
  • 03
    Nov
CMTG Claros Mortgage
$16.97 /

-0.06 (-0.35%)

Hot Stocks
European Commission approves KEYTRUDA plus LENVIMA for advanced RCC » 06:50
11/29/21
11/29
06:50
11/29/21
06:50
MRK

Merck

$78.65 /

-3.65 (-4.43%)

, ESALY

Eisai

$62.28 /

+0.14 (+0.23%)

Merck and Eisai announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MRK Merck
$78.65 /

-3.65 (-4.43%)

ESALY Eisai
$62.28 /

+0.14 (+0.23%)

MRK Merck
$78.65 /

-3.65 (-4.43%)

05:29 Today Citi
Merck downgraded to Neutral from Buy at Citi
11/24/21 Truist
Merck price target raised to $95 from $92 at Truist
11/18/21 BMO Capital
Merck initiated with a Market Perform at BMO Capital
11/18/21 Stifel
Insmed fits similar 'profile' to Dicerna in terms of value, says Stifel
ESALY Eisai
$62.28 /

+0.14 (+0.23%)

10/08/21 Jefferies
Biogen price target lowered to $400 from $500 at Jefferies
09/30/21 RBC Capital
Prothena price target raised to $82 from $59 at RBC Capital
06/25/21 Morgan Stanley
Eisai downgraded to Equal Weight from Overweight at Morgan Stanley
06/17/21 JPMorgan
Eisai upgraded to Overweight from Neutral at JPMorgan
MRK Merck
$78.65 /

-3.65 (-4.43%)

MRK Merck
$78.65 /

-3.65 (-4.43%)

ESALY Eisai
$62.28 /

+0.14 (+0.23%)

MRK Merck
$78.65 /

-3.65 (-4.43%)

ESALY Eisai
$62.28 /

+0.14 (+0.23%)

MRK Merck
$78.65 /

-3.65 (-4.43%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.